These authors equally contributed.
Further genotype–phenotype correlation emerging from two families with PLP1 exon 4 skipping
Article first published online: 27 MAY 2013
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
Volume 85, Issue 3, pages 267–272, March 2014
How to Cite
Biancheri, R., Grossi, S., Regis, S., Rossi, A., Corsolini, F., Rossi, D. P., Cavalli, P., Severino, M. and Filocamo, M. (2014), Further genotype–phenotype correlation emerging from two families with PLP1 exon 4 skipping. Clinical Genetics, 85: 267–272. doi: 10.1111/cge.12154
The authors declare that they have no conflict of interest.
- Issue published online: 27 JAN 2014
- Article first published online: 27 MAY 2013
- Manuscript Revised: 26 MAR 2013
- Manuscript Accepted: 26 MAR 2013
- Manuscript Received: 22 JAN 2013
|cge12154-sup-0001-FigureS1.tif||TIFF image||203K||Fig S1. RT-PCR analysis in patients' fibroblasts. (a) Full-length cDNA was amplified with a set of primers encompassing exons 1–7. The analysis revealed a shorter DM20 product of 745-bp in size, corresponding to an anomalous isoform with the entire skipping of exon 4 in the two probands (lanes 2 and 3) compared to the two normal, nonaffected, controls (lanes 1 and 4) showing the expected product (914-bp). Note that the PLP product (1019-bp) is not visible in any of the samples likely due to the low amount of PLP transcribed in fibroblasts. (b) To selectively identify the PLP product, two consecutive nested PCRs were performed on full-length cDNA product: (i) the first nested PCR, performed by a set of primers lying on exons 1 and 3B, amplified the expected PLP product (558-bp) in both the patients (lanes 2 and 3) and the controls (lanes 1 and 4); (ii) the second nested PCR, performed with a set of primers lying on exons 3B and 7, revealed the expected product (565-bp) in normal controls (lanes 1 and 4), while a shorter product of 396-bp, corresponding to the entire skipping of exon 4, in the patients (lanes 2 and 3). Note that the primers lying on exon 3B are PLP sequence specific (details in Fig. 2). M: ΦX DNA HaeIII digested molecular weight marker; C: no template control.|
|cge12154-sup-0002-FigureS2.tif||TIFF image||100K||Fig S2. PLP1 exon 4-specific RT-PCR. The analysis, performed on RNA samples (extracted from fibroblasts), PCR amplified by a set of primers, lying on exons 2 and 4, showed the expected DM20 isoform (348 bp) in the normal, nonaffected, controls (lanes 3 and 4), while no product was present in the two probands (lanes 1 and 2). Note that the other expected product of 453 bp in size (PLP isoform) is not visible in any of the samples likely due to the low amount of PLP isoform transcribed in the fibroblasts. M: ΦX DNA HaeIII digested molecular weight marker; C: no template control.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.